Moreover, SLAMF7 also does not impact on phagocytosis induction by CD20 antibody rituximab nor associates with overall survival of Diffuse Large B-Cell Lymphoma patients. This evidence concerns the gene SLAMF7 and diffuse large B-cell lymphoma.